Cite

HARVARD Citation

    Francois, B. et al. (2021). Rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH) phase IIb randomised controlled trial. BMJ open. 11 (7), p. . [Online]. 
  
Back to record